Newco Tecregen AG has raised CHF10 million (US$12.5 million) to advance a novel way of regenerating the thymus in order to boost T-cell production and stimulate recovery of the immune system following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback